1. Home
  2. AIT vs HALO Comparison

AIT vs HALO Comparison

Compare AIT & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Applied Industrial Technologies Inc.

AIT

Applied Industrial Technologies Inc.

HOLD

Current Price

$302.95

Market Cap

10.9B

Sector

Industrials

ML Signal

HOLD

Logo Halozyme Therapeutics Inc.

HALO

Halozyme Therapeutics Inc.

HOLD

Current Price

$63.80

Market Cap

8.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AIT
HALO
Founded
1923
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.9B
8.8B
IPO Year
1994
2001

Fundamental Metrics

Financial Performance
Metric
AIT
HALO
Price
$302.95
$63.80
Analyst Decision
Buy
Buy
Analyst Count
5
11
Target Price
$317.50
$78.64
AVG Volume (30 Days)
248.0K
1.2M
Earning Date
04-28-2026
05-05-2026
Dividend Yield
0.69%
N/A
EPS Growth
2.95
N/A
EPS
7.79
2.56
Revenue
$21,485,000.00
$151,862,000.00
Revenue This Year
$7.79
$28.24
Revenue Next Year
$5.45
$12.56
P/E Ratio
$39.26
$24.97
Revenue Growth
N/A
N/A
52 Week Low
$213.78
$47.50
52 Week High
$309.67
$82.22

Technical Indicators

Market Signals
Indicator
AIT
HALO
Relative Strength Index (RSI) 64.72 42.42
Support Level $254.61 $63.85
Resistance Level N/A $65.40
Average True Range (ATR) 7.27 1.95
MACD 0.95 -0.39
Stochastic Oscillator 73.99 19.90

Price Performance

Historical Comparison
AIT
HALO

About AIT Applied Industrial Technologies Inc.

Applied Industrial Technologies Inc is a distributor of industrial products to the maintenance, repair, and operations market and the original equipment manufacturing industry. Further, the company provides engineering and design services for industrial and fluid power applications. The products include bearings, power transmission components, fluid power components and systems, industrial rubber products, linear motion components, safety products, oilfield supplies, and other industrial and maintenance supplies. The company's reportable segments are; Service Center Based Distribution which derives key revenue, and Engineered Solutions. Geographically, the company derives its key revenue from the United States and the rest from Canada and other countries.

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

Share on Social Networks: